EDN1 and breast neoplasm: Roquin2 inhibits tumor angiogenesis by selectively destabilizing proangiogenic gene transcripts, including ENG, EDN1, VEGFB, and PDGFC. Roquin2 expression was decreased in breast tumor tissues and cells.